Wissing, Michel D <br/><br/>
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.  [electronic resource] 

 -  International journal of cancer  Mar 2015 
 - E760-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.29231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abiraterone Acetate<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androstenes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Disease-Free Survival<br/>Docetaxel<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Retrospective Studies<br/>Taxoids--administration & dosage